COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1201: Articles 12001-12010  | Next

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults
Wanlapakorn, N., Suntronwong, N., Phowatthanasathian, H., Yorsaeng, R., Vichaiwattana, P., Thongmee, T., Auphimai, C., Srimuan, D., Thatsanatorn, T., Assawakosri, S., Kanokudom, S., Poovorawan, Y.
10.1101/2021.11.04.21265908 — Posted: 2021-11-04
Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants by Modular, Tetravalent, Bi-paratopic Antibodies
Miersch, S., Saberianfar, R., Chen, C., Sharma, N., Amarasinghe, G. K., Caruso, A., Caccuri, F., Zani, A., Novelli, G., Sidhu, S. S.
10.1101/2021.11.02.466984 — Posted: 2021-11-04
Coronavirus RNA synthesis takes place within membrane-bound sites
Doyle, N., Simpson, J., Hawes, P. C., Maier, H. J.
10.1101/2021.11.04.467246 — Posted: 2021-11-04
Marked enhancement of neutralizing antibody and IFN-γ T-cell responses by GX-19N DNA booster in mice primed with inactivated vaccine
Seo, Y. B., Shin, D., Suh, Y. S., Na, J., Ryu, J. I., Sung, Y. C.
10.1101/2021.11.02.467026 — Posted: 2021-11-04
Comparing protein-protein interaction networks of SARS-CoV-2 and (H1N1) influenza using topological features
Khojasteh, H., Khanteymoori, A., Olyaee, M. H.
10.1101/2021.11.02.463717 — Posted: 2021-11-04
Protein arginylation is regulated during SARS-CoV-2 infection
Macedo-da-Silva, J., Rosa-Fernandes, L., Gomes, V. d. M., Santiago, V. F., Molnar, C. M. S., Barboza, B. R., de Sousa, E. E., Durigon, E. L., Marinho, C. R. F., Wrenger, C., Marie, S. K. N., Palmisano, G.
10.1101/2021.11.02.466971 — Posted: 2021-11-04 Discussion: Offsite
Clinically observed deletions in SARS-CoV-2 Nsp1 affect protein stability and its ability to inhibit translation
Kumar, P., Schexnaydre, E., Rafie, K., Terenin, I., Hauryliuk, V., Carlson, L.-A.
10.1101/2021.11.03.467065 — Posted: 2021-11-04
Spatialized Epidemiological Forecasting applied to Covid-19 Pandemic at Departmental Scale in France
OLIVER, M., GEORGES, D., PRIEUR, C.
10.1101/2021.11.03.21265855 — Posted: 2021-11-04
Prevalence of Antibodies to SARS-CoV-2 following natural infection and vaccination in Irish Hospital Healthcare Workers; changing epidemiology as the pandemic progresses
allen, n., Brady, M., Ni Riain, U., Conlon, N., Domegan, L., Carrion Martin, I., Walsh, C., Doherty, L., Kerr, C., Higgins, E., Bergin, C., Fleming, C.
10.1101/2021.11.04.21265921 — Posted: 2021-11-04
Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC)
Peluso, M. J., Sans, H. M., Forman, C. A., Nylander, A. N., Ho, H.-e., Lu, S., Goldberg, S. A., Hoh, R., Tai, V., Munter, S. E., Chenna, A., Yee, B. C., Winslow, J. W., Petropoulos, C. J., Martin, J. N., Kelly, J. D., Durstenfeld, M. S., Hsue, P. Y., Hunt, P. W., Greene, M., Chow, F. C., Hellmuth, J., Henrich, T. J., Glidden, D. V., Deeks, S. G.
10.1101/2021.11.02.21265778 — Posted: 2021-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).